We are all fully aware of the devastation that coronavirus disease 2019 (COVID-19) has caused and continues to do so, but with effective vaccines now being approved, it is the closest that we have been to seeing a light at the end of the tunnel.
We are lucky to now have three vaccines approved for the UK. Pfizer-BioNTech and Moderna are an entirely new kind of vaccine compared to the Oxford-AstraZeneca.1 The Oxford-AstraZeneca vaccine makes use of an inactive cold virus to produce the coronavirus spike protein. The other two carry messenger RNA (mRNA) which instructs the body’s own cells to build the spike protein. This in turn stimulates the immune system to produce antibodies and activate T-cells which prepare the immune system to respond to any future exposure to the COVID-19 virus.1
In December, my colleagues and I started to receive in-depth material when the first vaccine (Pfizer-BioNTech) was approved. This included the appropriate training to ensure we were ready to start…
